Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

NCT00723086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Therapy, Prostatic Neoplasms

Interventions

DRUG: docetaxel (XRP6976)

Sponsor

Sanofi